Paraganglioma: all 108 studies
Page 2 of 2. Open to participants first (47), then studies with results posted, then the rest; newest registration first within each.
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- RAD001 in Pheochromocytoma or Nonfunctioning CarcinoidCompletedNCT01152827Phase 2
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Specificity of Elevated Plasma EM66 Levels in PheochromocytomaCompletedNCT01022515Not applicable
- Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and ParagangliomaTerminatedNCT00911729
- ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic CarcinoidCompletedNCT00339131Phase 1
- Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive CarriersCompletedNCT00188019Not applicable